Clinical Trials Logo

Hot Flashes clinical trials

View clinical trials related to Hot Flashes.

Filter by:
  • Active, not recruiting  
  • « Prev · Page 2

NCT ID: NCT00667121 Active, not recruiting - Breast Cancer Clinical Trials

Tamoxifen in Women With Breast Cancer and in Women at High-Risk of Breast Cancer Who Are Receiving Venlafaxine, Citalopram, Escitalopram, Gabapentin, or Sertraline

Start date: March 16, 2011
Phase:
Study type: Observational

RATIONALE: Studying samples of blood in the laboratory from patients receiving tamoxifen may help doctors learn more about the effects of other drugs on the level of tamoxifen in the blood. PURPOSE: This clinical trial is studying levels of tamoxifen in the blood of women with breast cancer and in women at high risk of breast cancer who are receiving tamoxifen together with venlafaxine, citalopram, escitalopram, gabapentin, or sertraline.

NCT ID: NCT00079248 Active, not recruiting - Breast Cancer Clinical Trials

Hormone Replacement Therapy in Relieving Menopausal Symptoms in Postmenopausal Women With Previous Stage I or Stage II Breast Cancer

Start date: March 2002
Phase: N/A
Study type: Interventional

RATIONALE: Hormone replacement therapy may be effective in relieving symptoms of menopause, such as hot flashes, night sweats, and vaginal dryness, without causing a recurrence of breast cancer. PURPOSE: This randomized clinical trial is studying hormone replacement therapy to see how well it works in relieving symptoms of menopause in postmenopausal women with previous stage I or stage II breast cancer.

NCT ID: NCT00020865 Active, not recruiting - Lymphoma Clinical Trials

Levofloxacin Compared With Cefepime in Treating Cancer Patients With Fever and Neutropenia

Start date: September 2001
Phase: Phase 3
Study type: Interventional

RATIONALE: Levofloxacin may be effective in reducing fever and controlling other symptoms of neutropenia in patients who are being treated for cancer. It is not yet known whether levofloxacin is more effective than cefepime in reducing fever and controlling symptoms of neutropenia. PURPOSE: Randomized phase III trial to compare the effectiveness of levofloxacin with that of cefepime in reducing fever and controlling symptoms of neutropenia in patients who are being treated for cancer.